Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

lanreotide nanotubes with acetate counterions

Based on

1 Articles
2012 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

acetate ion

Type Single Compound
Formula C2H3O21-
Role core
2

H-D-2-Nal1-cyclo(Cys2-Tyr3-D-Trp4-Lys5-Val6-Cys7)-Thr8-NH2

lanreotide
Type Single Compound
Formula C54H69N11O10S2
Role layer
3

acetate ion

Type Single Compound
Formula C2H3O21-
Role layer

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
critical aggregation concentration

More information/entries available to subscribers only.

Or, view sample content

Applications

Characterization

Method Nanomaterial Variant Source
small angle X-ray diffraction

More information available to subscribers only.

Or, view sample content

Biological effects

Preparation

Method 1

Type: Chemical synthesis
Source:
Starting materials
  • methanecarboxylic acid
  • H-D-2-Nal1-cyclo(Cys2-Tyr3-D-Trp4-Lys5-Val6-Cys7)-Thr8-NH2
  1. aSsGgCnhGrZbgWh
Product

lanreotide nanotubes with acetate counterions

Diameter: 24.4 nm

Length: > 100000 nm

Spacing: 12.2 nm

Wall thickness: 1.8 nm

Medium/Support: none

Method 2

Type: Chemical synthesis
Source:
Starting materials
  • methanecarboxylic acid
  • H-D-2-Nal1-cyclo(Cys2-Tyr3-D-Trp4-Lys5-Val6-Cys7)-Thr8-NH2
  1. YFC3iJYBwKp6DTh2dk7xy4hYFPD6RFzU9dS9Q3C4
Product

lanreotide nanotubes with acetate counterions

Diameter: 24.4 nm

Length: > 100000 nm

Spacing: 12.2 nm

Wall thickness: 1.8 nm

Medium/Support: none

Method 3

Type: Chemical synthesis
Source:
Starting materials
  • H-D-2-Nal1-cyclo(Cys2-Tyr3-D-Trp4-Lys5-Val6-Cys7)-Thr8-NH2
  • methanecarboxylic acid
  1. PLprE0nJOjwolPxWsvJxGm7WZWGyUDx1tNv6Qnj
Product

lanreotide nanotubes with acetate counterions

Diameter: 24.4 nm

Length: > 100000 nm

Spacing: 12.2 nm

Wall thickness: 1.8 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial